MANILA NephroPlus, Asia’s largest dialysis network (Source: Frost & Sullivan Report), has significantly strengthened its presence in the Philippines with the acquisition of six new dialysis clinics. This strategic expansion brings the company’s total footprint in the country to 39 clinics, delivering high-quality, patient-centric care to over 2,093 patients nationwide.
The newly acquired clinics are located in:
- Zamboanga City
- Santiago, Isabela
- Cabuyao, Laguna
- Binondo, Manila
- CP Garcia Avenue, Diliman, Quezon City
- E. Rodriguez Avenue, Quezon City
This acquisition is part of NephroPlus’s broader international growth strategy and underscores its long-term commitment to the Philippines. The company continues to invest in enhancing operational efficiency, clinical excellence, and access to dialysis services across the country.
NephroPlus is renowned for its use of advanced technology and data-driven care models, including remote patient monitoring and real-time clinical data analytics, which enable superior clinical outcomes and operational performance.
With a network of 490+ clinics across five countries and more than 290 cities, NephroPlus provides life-sustaining dialysis treatment to over 32,000 patients every month, positioning it as a global leader in kidney care. (Source: Frost & Sullivan Report)
Rohit Singh, Group CEO of NephroPlus, commented: “This expansion marks a major milestone in our journey in the Philippines, which has now become our second-largest country of operations after India. We are deeply honored by the trust placed in us by doctors, patients, and the broader healthcare ecosystem. As we grow, we remain steadfast in our mission to support the Philippines’ goal of achieving universal health coverage—through infrastructure development, clinical innovation, workforce capacity-building, and an unwavering focus on delivering patient-first care.”
This development reaffirms NephroPlus’s commitment to making world-class, affordable dialysis care accessible to more patients across Asia and beyond.